Sorafenib combined with embolization plus hepatic arterial infusion chemotherapy for inoperable hepatocellular carcinoma

BACKGROUND: There is little evidence of combining sorafenib with hepatic arterial infusion chemotherapy (HAIC) after transarterial chemoembolization (TACE) for intermediate and advanced hepatocellular carcinoma (HCC). It is important to identify that patients with intermediate and advanced HCC are m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J Gastrointest Oncol
Main Authors: Liu, Bao-Jiang, Gao, Song, Zhu, Xu, Guo, Jian-Hai, Zhang, Xin, Chen, Hui, Wang, Xiao-Dong, Yang, Ren-Jie
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Inc 2020
Assuntos:
Observational Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7341000/
https://ncbi.nlm.nih.gov/pubmed/32699581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v12.i6.663
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados